Warkentin, T E <br/><br/>
Limitations of conventional treatment options for heparin-induced thrombocytopenia.  [electronic resource] 

 -  Seminars in hematology  Oct 1998 
 - 17-25; discussion 35-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>0037-1963 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ancrod--therapeutic use<br/>Anticoagulants--therapeutic use<br/>Chondroitin Sulfates--therapeutic use<br/>Dermatan Sulfate--therapeutic use<br/>Drug Combinations<br/>Heparin--adverse effects<br/>Heparin, Low-Molecular-Weight--therapeutic use<br/>Heparitin Sulfate--therapeutic use<br/>Humans<br/>Thrombocytopenia--chemically induced<br/>Warfarin--adverse effects